Pocket Plane Selection – Breast Implants Toronto

Subpectoral breast implant placement refers to partial muscle coverage underneath the pectoralis major muscle. The breast implant is subglandular in its lower portion to a variable degree in these cases. Complete sub-muscular coverage involving mobilization of the serratus anterior muscle and anterior rectus sheath is useful for tissue expanders in breast reconstruction but not appropriate for aesthetic breast augmentation. Placement below the muscle is believed to contribute to a decreased incidence of capsular contracture. It is unequivocally helpful in most patients to obscure superior pole breast implant shape and minimize the potential for perceptible ripples with saline breast implant use. Previously, with the widespread use of silicone gel breast implants Toronto in primary augmentation, subglandular placement was popular because it simplified the procedure and minimized postoperative patient discomfort and recovery. It has also been claimed that sub-pectoral breast implant placement is advantageous for breast cancer monitoring, although the ratio of breast implant volume to breast tissue volume is likely a more important variable. Large breast implants with a small native breast volume stretched in front impair mammogram interpretation far more than the difference in effect between sub-glandular and subpectoral placement of an average size breast implant Toronto. Subpectoral breast implant Toronto placement is indicated in most cases of primary breast augmentation except for patients with normal body habitus (not excessively thin) who present with significant postpartum atrophy and exhibit loose breast skin, glandular ptosis, and significant residual breast volume (more than 200 g per side). Sub-glandular augmentation in these individuals more effectively restores shape without the risk of visible breast implant Toronto shape. Subpectoral breast implant placement in these individuals may fail to correct ptosis completely, which may result in an abnormal double breast contour.

Currently, a large body of both scientific evidence and opinion exists indicating the absence of association of diseases with silicone Toronto breast implants and the lack of any causal association with cancer. Good long-term studies in the United States, Denmark, Canada, and Sweden have shown a lower than expected risk of breast cancer in women who have undergone augmentation. In November of 2006, the U.S. Food and Drug Administration lifted the specific restrictions on the use of silicone gel breast implants Toronto for primary breast augmentation.

The necessity for revisionary surgery in breast augmentation has been reported as possibly the highest of any aesthetic procedure performed by plastic surgeons today—approximately 20 percent. Evidence exists that submuscular augmentation potentially interferes less with screening mammography than does the subglandular position, and this should be mentioned.